Cargando…

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

BACKGROUND: Withdrawal of antiseizure medication treatment (ASM) can be considered after completion of antitumour treatment in glioma patients who no longer suffer from seizures. We compared the risk for recurrent seizures after ASM withdrawal between patients with short-term, medium-term versus lon...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kerkhof, Melissa, Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589365/ https://www.ncbi.nlm.nih.gov/pubmed/37755633 http://dx.doi.org/10.1007/s11060-023-04450-z

Ejemplares similares

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Video-EEG-monitoring to guide antiseizure medication withdrawal
por: Dhaenens-Meyer, Laurien K. L., et al.
Publicado: (2023)

Comparison of Long-Term Outcomes of Monotherapy and Polytherapy in Seizure-Free Patients With Epilepsy Following Antiseizure Medication Withdrawal
por: Wang, Yuxuan, et al.
Publicado: (2021)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy
por: Komatsubara, Takao, et al.
Publicado: (2022)

Commentary — Early discontinuation of antiseizure medication in neonatal seizures - Proceed with caution
por: Volpe, J.J.
Publicado: (2022)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Capturing seizures in clinical trials of antiseizure medications for KCNQ2‐DEE
por: Millichap, John J., et al.
Publicado: (2021)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Determinants and predictors for the long-term disease burden of intracranial meningioma patients
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2020)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2021)

Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members
por: Terman, Samuel W., et al.
Publicado: (2023)

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures
por: Glass, Hannah C., et al.
Publicado: (2021)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Interaction of Varenicline with Classic Antiseizure Medications in the Mouse Maximal Electroshock-Induced Seizure Model
por: Bernat, Piotr, et al.
Publicado: (2023)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy
por: Kerkhof, M., et al.
Publicado: (2018)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022)

Dexamethasone-induced withdrawal seizure
por: Mahar, Santwana, et al.
Publicado: (2015)

Epidemiology and injectable antiseizure medication treatment patterns of seizure patients treated in United States hospitals
por: Beaty, Silky, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jp6iq2hs4phjotlmb96enor7c4